Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy for first-line treatment of advanced non-small cell lung cancer: A generic protocol Journal Article
| Authors: | Syn, N. L. X.; Roudi, R.; Wang, L. Z.; Wang, L.; Loh, M.; Huang, Y.; Ou, S. H. I.; Soong, R.; Drilon, A.; Wee, I. |
| Article Title: | Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy for first-line treatment of advanced non-small cell lung cancer: A generic protocol |
| Abstract: | This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the effectiveness and toxicity of immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy alone as first-line treatment of advanced non-small cell lung cancer (NSCLC). © 2018 The Cochrane Collaboration. |
| Keywords: | adult; unclassified drug; overall survival; advanced cancer; cancer combination chemotherapy; drug safety; antineoplastic agent; cancer immunotherapy; progression free survival; quality of life; clinical protocol; immunomodulating agent; non small cell lung cancer; randomized controlled trial (topic); comparative effectiveness; immune checkpoint inhibitor; human; priority journal; article |
| Journal Title: | Cochrane Database of Systematic Reviews |
| Volume: | 2018 |
| Issue: | 4 |
| ISSN: | 1469-493X |
| Publisher: | John Wiley & Sons |
| Date Published: | 2018-01-01 |
| Start Page: | CD013009 |
| Language: | English |
| DOI: | 10.1002/14651858.cd013009 |
| PROVIDER: | scopus |
| PMCID: | PMC6494557 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 June 2018 -- Source: Scopus |
